Exploratory Study of Pagoclone in Men With Premature Ejaculation.

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to evaluate pagoclone in the treatment of premature ejaculation.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Endo Pharmaceuticals

Criteria

Inclusion Criteria:

• A male regularly experiencing premature ejaculation

• 18 to 55 yrs old

• In a Stable relationship with one woman for at least 6 months